CONMED | CNMD - Current Assets


CONMED reported $670.59M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
3M USD 14.39B 1.99B Mar/2026
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AtriCure USD 313.69M 8.82M Mar/2026
Avanos Medical USD 325M 30.4M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
CONMED USD 670.59M 2.27M Mar/2026
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Masimo USD 870.5M 55.5M Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Olympus JPY 706.31B 53.66B Mar/2026
Orthofix International USD 461.52M 44.67M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026